RE: Omega wins first antibody test order9 Jun 2020 12:37
Omega Diagnostics PLC - Alva-based medical diagnostics - Expects Ebitda for year ended March between GBP850,000 to GBP900,000, ahead of market expectations and up from GBP199,668. Signs long-term supply agreement with Mologic Ltd, for the supply of raw materials for Omega to manufacture its CE-Marked ELISA antibody test. Also signs material transfer agreement with Mologic. Announces first order for test to Senegal worth GBP100,000.